CW
ABBV icon

CreativeOne Wealth’s AbbVie ABBV Stock Holding History

CreativeOne Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Buy
46,488
+1,607
+4% +$346K 0.25% 70
2026
Q1 		$9.76M Sell
44,881
-963
-2% -$214K 0.23% 83
2025
Q4 		$10.5M Sell
45,844
-161
-0.3% -$36.7K 0.25% 73
2025
Q3 		$10.7M Buy
46,005
+1,552
+3% +$316K 0.26% 73
2025
Q2 		$8.25M Buy
44,453
+2,236
+5% +$416K 0.22% 89
2025
Q1 		$8.85M Buy
42,217
+1,712
+4% +$333K 0.26% 77
2024
Q4 		$7.2M Buy
40,505
+2,979
+8% +$548K 0.22% 91
2024
Q3 		$7.41M Buy
37,526
+8,706
+30% +$1.62M 0.25% 85
2024
Q2 		$4.94M Sell
28,820
-3,670
-11% -$608K 0.25% 85
2024
Q1 		$5.92M Buy
32,490
+19,087
+142% +$3.29M 0.24% 84
2023
Q4 		$2.08M Sell
13,403
-3,606
-21% -$526K 0.13% 152
2023
Q3 		$2.54M Sell
17,009
-19,590
-54% -$2.88M 0.18% 111
2023
Q2 		$4.93M Buy
36,599
+1,331
+4% +$195K 0.23% 82
2023
Q1 		$5.62M Sell
35,268
-898
-2% -$137K 0.28% 70
2022
Q4 		$5.84M Buy
36,166
+707
+2% +$108K 0.32% 71
2022
Q3 		$4.76M Buy
35,459
+8,405
+31% +$1.21M 0.29% 74
2022
Q2 		$4.14M Buy
27,054
+8,439
+45% +$1.29M 0.22% 75
2022
Q1 		$3.02M Buy
18,615
+4,837
+35% +$703K 0.16% 105
2021
Q4 		$1.86M Buy
13,778
+1,546
+13% +$183K 0.09% 197
2021
Q3 		$1.32M Buy
12,232
+680
+6% +$77.7K 0.08% 223
2021
Q2 		$1.3M Buy
11,552
+4,329
+60% +$488K 0.08% 203
2021
Q1 		$782K Buy
7,223
+138
+2% +$14.8K 0.06% 243
2020
Q4 		$759K Buy
7,085
+3,803
+116% +$365K 0.06% 223
2020
Q3 		$287K Buy
3,282
+206
+7% +$19.4K 0.04% 215
2020
Q2 		$302K Buy
3,076
+351
+13% +$30.9K 0.05% 191
2020
Q1 		$208K Buy
2,725
+130
+5% +$11.1K 0.04% 185
2019
Q4 		$229K Buy
+2,595
New +$215K 0.04% 196

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CreativeOne Wealth's ABBV Position: Q2 2026 in Review

CreativeOne Wealth increased its AbbVie (ABBV) stake by 3.6% in Q2 2026, buying an estimated $346K and bringing the position to 46,488 shares worth $11.7M. The position accounts for 0.25% of the portfolio, ranked #70.

CreativeOne Wealth first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • CreativeOne Wealth held 46,488 shares of AbbVie worth $11.7M as of Q2 2026.
  • CreativeOne Wealth bought 1,607 AbbVie shares in Q2 2026, an estimated $346K.
  • AbbVie made up 0.25% of CreativeOne Wealth's portfolio in Q2 2026, its #70 holding.
  • CreativeOne Wealth first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on CreativeOne Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.